Specifically looking at biomarkers, we showed that intraretinal hyperreflective foci, hard exudates, were markedly lower in the faricimab arms compared to the aflibercept 2-mg arms. And then also ...
GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, ...
Perilipin 5 as mediator of high-fat diet-induced hepatocellular carcinoma immune escape by stabilization of PD-L1 expression. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...
EyePoint (EYPT) announced details for its pivotal Phase 3 program evaluating Duravyu for the treatment of diabetic macular edema with first ...
BALLERUP, Denmark--(BUSINESS WIRE)--NOT FOR UK USE – NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today announced positive results from the Phase 2a Mechanism of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback